Chembio Diagnostics Inc. buy stratec
Start price
01.04.20
/
50%
€6.55
Target price
04.11.21
€15.00
Performance (%)
-71.76%
End price
05.11.21
€1.85
Summary
This prediction ended on 05.11.21 with a price of €1.85. Massive losses of -71.76% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chembio Diagnostics Inc. | - | - | - | - |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% | 53.464% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% | 72.276% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% | 63.079% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% | 60.400% |
Comments by stratec for this prediction
In the thread Chembio Diagn.new diskutieren
Kantor Fitzgerald erneuert sein Buy-Rating mit $7-Preisziel. Chembio Diagnostik stellt Point-of-Care (POC)-Diagnosetests her, die zur Erkennung oder Diagnose von Krankheiten verwendet werden.
Kursziel geändert auf 15,0
In the thread Trading Chembio Diagn.new
Die von stratec gewählte maximale Laufzeit wurde überschritten